Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_238698
http://purl.obolibrary.org/obo/CHEBI_238698
|
|---|---|
| Preferred Name | bevantolol |
| Synonyms |
[2-(3,4-dimethoxyphenyl)ethyl][2-hydroxy-3-(3-methylphenoxy)propyl]amine
(+-)-bevantolol
bevantolol
1-(3,4-dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol
1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol
1-(3,4-dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol
1-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-3-(3-methylphenoxy)propan-2-ol
bevantololum
C20H27NO4
1-((2-(3,4-dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | bevantolol
|
|---|---|
| label | bevantolol
|
| DBSynonym |
bevantololum [inn-latin]
1-(3,4-dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol
|
| ATCCode | C07AB06
|
| Definition | A propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydroxy group is substituted by 3-methylphenyl and one of the hydrogens attached to the nitrogen is substituted by 2-(3,4-dimethoxyphenyl)ethyl. A beta1 adrenoceptor antagonist, it has been shown to be as effective as other beta-blockers for the treatment of angina pectoris and hypertension.
|
| has pharmacological target | |
| type | |
| has role | |
| InChIKey | InChIKey=HXLAFSUPPDYFEO-UHFFFAOYSA-N
|
| blocks | |
| Synonym |
[2-(3,4-dimethoxyphenyl)ethyl][2-hydroxy-3-(3-methylphenoxy)propyl]amine
(+-)-bevantolol
bevantolol
1-(3,4-dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol
1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol
1-(3,4-dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol
1-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-3-(3-methylphenoxy)propan-2-ol
bevantololum
C20H27NO4
1-((2-(3,4-dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol
See more
See less
|
| xref |
PubChem Compound:2372
Patent:US4994618
CiteXplore:2871781
PubChem Substance:46506014
CiteXplore:2894292
ChEBI:238698
Patent:US3857891
PharmGKB:PA164743236
Beilstein:2769444
DrugBank:DB01295
ChemSpider:2282
Reaxys:2769444
CASRN:59170-23-9
Patent:BE790165
See more
See less
|
| CASRN | 59170-23-9
|
| prefixIRI | obo2:CHEBI_238698
|
| SMILES |
COC1=C(OC)C=C(CCNCC(O)COC2=CC=CC(C)=C2)C=C1
COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC
|
| may interact with |
See more
See less
|
| DBname | bevantolol
|
| InChI | InChI=1S/C20H27NO4/c1-15-5-4-6-18(11-15)25-14-17(22)13-21-10-9-16-7-8-19(23-2)20(12-16)24-3/h4-8,11-12,17,21-22H,9-10,13-14H2,1-3H3
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |